<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-KO4S4RSN</identifier><date>2017</date><creator>Bratkovič, Tomaž</creator><relation>documents/doc/K/URN_NBN_SI_doc-KO4S4RSN_001.pdf</relation><relation>documents/doc/K/URN_NBN_SI_doc-KO4S4RSN_001.txt</relation><format format_type="issue">5</format><format format_type="volume">68</format><format format_type="type">article</format><format format_type="extent">str. 345-354</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">4454769</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-KO4S4RSN</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">biološka aktivnost proteinov</subject><subject language_type_id="slv">Biološka zdravila</subject><subject language_type_id="slv">Imunogenost</subject><subject language_type_id="slv">protitelesa proti učinkovini</subject><title>Immunogenicity of biological drugs</title><title>Imunogenost bioloških zdravil</title></Record>